Healthcare Sector

SNY

Market Tracker

$44.60
-0.74
(-1.63%)
2:25 pm
Next Earnings: (est.) n/a
  • SNY (Selected)

    Sanofi

SNY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

SNY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

SNY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

SNY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

SNY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

SNY Major Holders

Name Pct Held Shares Total
Dodge & Cox Stock Fund 22.47% 59.88M 3.1B
Dodge & Cox Balanced Fund 2.57% 6.84M 354.7M
John Hancock Mutual Fds III-Disciplined Value Fd 2.41% 6.43M 333.29M
Invesco Comstock Fd 1.28% 3.41M 176.55M
Fidelity Equity Dividend Income Fund 1.22% 3.25M 168.45M
Fidelity Series Value Discovery Fund 1.03% 2.75M 142.42M
Fidelity Strategic Advisers Fidelity U.S. Total Stock Fund 0.76% 2.03M 105.23M
Fidelity Select Portfolios - Pharmaceuticals 0.50% 1.33M 69.05M
First Tr Exchange Traded Fd-First Tr Value Line Dividend Index 0.50% 1.33M 68.95M
Vanguard/Windsor II 0.50% 1.32M 68.44M

SNY News

  • Cytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market

    03/05 05:44 am

    GlobeNewswire Inc.

    Read more
  • Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

    03/03 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

    03/02 05:59 am

    GlobeNewswire Inc.

    Read more
  • Communiqué de presse: L’acoziborole Winthrop, développé par DNDi et Sanofi, reçoit l’avis positif du CHMP comme traitement à dose unique à trois comprimés pour la forme la plus fréquente de la maladie du sommeil

    02/27 06:55 am

    GlobeNewswire Inc.

    Read more
  • Press Release: Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness

    02/27 06:55 am

    GlobeNewswire Inc.

    Read more
  • Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update

    02/24 05:00 pm

    GlobeNewswire Inc.

    Read more
  • Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition

    02/24 02:47 pm

    Benzinga

    Read more
  • FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer

    02/18 11:10 am

    Benzinga

    Read more
  • Turner Syndrome Market Size to Reach USD 3.67 Billion by 2033, Fueled by Early Diagnosis Advances and Rising Awareness of Rare Chromosomal Disorders – SNS Insider

    02/18 06:55 am

    GlobeNewswire Inc.

    Read more
  • Press release: Filing of the 2025 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

    02/17 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel, et du « Form 20-F » américain

    02/17 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Teva Pharmaceutical's New Study Shows Lasting Relief For Inflammatory Bowel Disease Patients

    02/17 08:04 am

    Benzinga

    Read more
  • Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

    02/17 07:00 am

    GlobeNewswire Inc.

    Read more
  • Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

    02/17 07:00 am

    GlobeNewswire Inc.

    Read more
  • Communiqué de presse : Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn

    02/17 07:00 am

    GlobeNewswire Inc.

    Read more
  • Uterine Fibroid Market Size to Reach USD 9.43 Billion by 2033 with 7.63% CAGR – SNS Insider

    02/16 09:00 am

    GlobeNewswire Inc.

    Read more
  • Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors

    02/13 09:23 am

    Benzinga

    Read more
  • NIH Stops Johnson & Johnson's Blood Thinner Drug Arm In Stroke Trial After Safety Review (UPDATED)

    02/12 03:55 pm

    Benzinga

    Read more
  • Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'

    02/12 07:28 am

    Benzinga

    Read more
  • Press Release: Sanofi completes the acquisition of Dynavax

    02/10 10:00 am

    GlobeNewswire Inc.

    Read more
  • Communiqué de presse : Sanofi finalise l’acquisition de Dynavax

    02/10 10:00 am

    GlobeNewswire Inc.

    Read more
  • Anti-Obesity Drugs Market to Reach US$195.99 Billion by 2036 as GLP-1 Therapies Drive a Structural Shift in Weight Management

    02/06 06:00 am

    GlobeNewswire Inc.

    Read more
  • Obesity Treatment Market Size to Reach USD 75.69 Billion by 2033 as the Treatment Offers a Comprehensive Evaluation of Therapeutic Developments Globally

    02/05 05:00 am

    GlobeNewswire Inc.

    Read more
  • Human Vaccines Market Size to Reach USD 62.45 Billion by 2033, Driven by Expanding Immunization Programs – SNS Insider

    02/05 04:57 am

    GlobeNewswire Inc.

    Read more
  • Sanofi Plans Regulatory Submission For Investigational Drug For Rare Disease Despite Mixed Data From Pivotal Trials

    02/02 09:30 am

    Benzinga

    Read more
  • Regeneron Posts Lower Eylea Sales Amid Rising Competition, Plans $2 Billion New Factory

    01/30 11:56 am

    Benzinga

    Read more
  • Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News

    01/30 10:33 am

    The Motley Fool

    Read more
  • Sanofi Warns Dupixent Is Too Big To Replace As Patent Clock Ticks

    01/29 08:08 am

    Benzinga

    Read more
  • Atopic Dermatitis Market to Reach USD 12.97 Billion by 2034, Growing at 7.75% CAGR

    01/27 11:00 am

    GlobeNewswire Inc.

    Read more
  • Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag

    01/26 11:06 am

    Benzinga

    Read more
  • Sanofi Plans Regulatory Filings For Dupixent's Successor Despite Mixed Data From Pivotal Studies

    01/23 08:02 am

    Benzinga

    Read more
  • FDA Shows Caution, Delays Trump-Backed Fast-Track Drugs Over Risks (UPDATED)

    01/16 09:32 am

    Benzinga

    Read more
  • Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

    01/13 08:00 am

    GlobeNewswire Inc.

    Read more
  • Regeneron Just Moved From Underperform To Buy - Here's Why

    01/07 05:18 pm

    Benzinga

    Read more
  • FDA Flags Liver Injury Risk In Sanofi's Rejected Multiple Sclerosis Drug

    01/06 09:54 am

    Benzinga

    Read more
  • Cytokinetics to Present at the 44th Annual J.P. Morgan Healthcare Conference

    01/05 05:00 pm

    GlobeNewswire Inc.

    Read more
  • $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX)

    01/05 03:22 pm

    Benzinga

    Read more
  • Drugmakers Plan Fresh Price Hikes On 350 Medicines In 2026

    12/31 09:59 am

    Benzinga

    Read more
  • Stock Market Today: Records, Metals Mania and Mixed Tech Tape

    12/25 02:07 am

    Investing.com

    Read more
  • Why Dynavax Stock Soared Today

    12/24 04:35 pm

    The Motley Fool

    Read more
  • Sanofi Makes $2.2 Billion Bet On Adult Vaccines With Dynavax Buy

    12/24 07:21 am

    Benzinga

    Read more
  • Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

    12/19 05:00 pm

    GlobeNewswire Inc.

    Read more
  • Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies

    12/17 11:00 am

    GlobeNewswire Inc.

    Read more
  • Communiqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire »

    12/17 02:30 am

    GlobeNewswire Inc.

    Read more
  • Press release: Availability of the Q4 2025 Aide memoire

    12/17 02:30 am

    GlobeNewswire Inc.

    Read more
  • Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration

    12/15 02:10 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: